Puma Biotechnology
World Rank (Jan-05-2024)
17,684
Market Cap (Jan-05-2024)
0.208 Billion USD
World Rank (Jul-30-2023)
18,982
Market Cap (Jul-30-2023)
0.168 Billion USD
World Rank (Dec-25-2022)
18,277
Market Cap (Dec-25-2022)
0.191 Billion USD
World Rank (Jan-07-2022)
22,160
Market Cap (Jan-07-2022)
0.11 Billion USD
Annual Revenue in USD
225 Million USD
Annual Net Income in USD
-60 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Company Profile
Puma Biotechnology is a Biopharmaceutical company focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use. The company annual revenue is 272.1 million USD and 272 employees as on 2020. The headquarters is in USA.
Company Website